BMY FY 2011 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$120B

FY 2011 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$21.2B+9.0% YoY

Gross Profit

$15.7B74.0% margin

Operating Income

$6.8B31.8% margin

Net Income

$3.7B17.5% margin

EPS (Diluted)

$2.16

Cash Flow

Operating Cash Flow

$4.8B

Free Cash Flow

$4.5B

Stock-Based Comp.

$161M

Balance Sheet

Total Assets

$33.0B

Total Liabilities

$17.1B

Stockholders' Equity

$16.0B

Cash & Equivalents

$5.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21.2B	$19.5B	+9.0%
Gross Profit	$15.7B	$14.3B	+9.7%
Operating Income	$6.8B	$6.1B	+10.0%
Net Income	$3.7B	$3.1B	+19.6%